Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1

Conditions

Warts 1High-grade Anal Intraepithelial Neoplasia 1Carcinoma, Basal Cell 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 328Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 280Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × green tea extract polyphenone E × Clear all
NCT04055142 2024-07-10

TreatAIN

Hospital Universitari Vall d'Hebron Research Institute

Phase 3 Completed
108 enrolled

High-grade Anal Intraepithelial Neoplasia

NCT02622568 2017-09-08

Investigating Veregen â„¢ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study

University of Texas Southwestern Medical Center

Phase 4 Completed
28 enrolled 7 charts

Warts

NCT02029352 2016-05-18

Topical Green Tea Ointment in Treatment of Superficial Skin Cancer

Maastricht University Medical Center

Phase 2/3 Completed
42 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡